These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29209775)

  • 1. Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).
    Takayama T; Hiro T; Yoda S; Fukamachi D; Haruta H; Kogo T; Mineki T; Murata H; Oshima T; Hirayama A
    Heart Vessels; 2018 Jun; 33(6):590-594. PubMed ID: 29209775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital assessment of endothelial function and ischemic heart disease in women.
    Matsuzawa Y; Sugiyama S; Sugamura K; Nozaki T; Ohba K; Konishi M; Matsubara J; Sumida H; Kaikita K; Kojima S; Nagayoshi Y; Yamamuro M; Izumiya Y; Iwashita S; Matsui K; Jinnouchi H; Kimura K; Umemura S; Ogawa H
    J Am Coll Cardiol; 2010 Apr; 55(16):1688-96. PubMed ID: 20394872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT).
    Koyama T; Tanaka A; Yoshida H; Oyama JI; Toyoda S; Sakuma M; Inoue T; Otsuka Y; Node K
    Heart Vessels; 2018 Aug; 33(8):958-964. PubMed ID: 29427024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Kawashiri MA; Yamagishi M; Sakamoto T; Takayama T; Hiro T; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Ther; 2013 Dec; 31(6):335-43. PubMed ID: 23409830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study.
    Kono Y; Fukuda S; Shimada K; Nakanishi K; Otsuka K; Kubo T; Jissho S; Taguchi H; Yoshikawa J; Yoshiyama M
    Drug Des Devel Ther; 2013; 7():369-74. PubMed ID: 23667308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Catheter Sheath Insertion into the Radial Artery on Vascular Endothelial Function Assessed by Reactive Hyperemia Peripheral Arterial Tonometry.
    Nakata T; Ikeda S; Koga S; Yoshida T; Koide Y; Kawano H; Maemura K; Kohno S
    Int Heart J; 2015; 56(5):489-94. PubMed ID: 26370365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia.
    Bonetti PO; Pumper GM; Higano ST; Holmes DR; Kuvin JT; Lerman A
    J Am Coll Cardiol; 2004 Dec; 44(11):2137-41. PubMed ID: 15582310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.
    Egede R; Jensen LO; Hansen HS; Antonsen L; Hansen KN; Junker A; Thayssen P
    Int J Cardiol; 2012 Jul; 158(3):376-9. PubMed ID: 21349594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranolazine improves endothelial function in patients with stable coronary artery disease.
    Deshmukh SH; Patel SR; Pinassi E; Mindrescu C; Hermance EV; Infantino MN; Coppola JT; Staniloae CS
    Coron Artery Dis; 2009 Aug; 20(5):343-7. PubMed ID: 19444092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
    Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
    Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia.
    Demir V; Doğru MT; Ede H; Yilmaz S; Alp C; Celik Y; Yildirim N
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):162-166. PubMed ID: 29528361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease.
    Nakamura T; Uematsu M; Yoshizaki T; Kobayashi T; Watanabe Y; Kugiyama K
    J Cardiol; 2020 Mar; 75(3):270-274. PubMed ID: 31500961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy.
    Philpott AC; Hubacek J; Sun YC; Hillard D; Anderson TJ
    Atherosclerosis; 2013 Feb; 226(2):453-8. PubMed ID: 23174368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
    Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
    JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease].
    Sergienko IV; Samoĭlenko EIu; Masenko VP; Ezhov MV; Sumarokov AB; Tkachev GA; Pogorelova OA; Balakhonova TV; Naumov VG
    Kardiologiia; 2006; 46(5):4-8. PubMed ID: 16858347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
    Ferdinand KC; Davidson MH; Kelly MT; Setze CM
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
    Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
    Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.
    Garg N; Krishan P; Syngle A
    Clin Rheumatol; 2015 Jun; 34(6):1065-71. PubMed ID: 25771851
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.